Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, October 2008, p. 3783-3785, Vol. 52, No. 10
0066-4804/08/$08.00+0 doi:10.1128/AAC.00473-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
George R. Thompson III,1*
Nathan P. Wiederhold,1,3,4
Ana C. Vallor,1
Nyria C. Villareal,1
James S. Lewis II,1,2 and
Thomas F. Patterson1
University of Texas Health Science Center at San Antonio, Department of Internal Medicine, Division of Infectious Diseases, MSC 7881, 7703 Floyd Curl Drive, San Antonio, Texas 78229,1
Department of Pharmacy, University Health System, San Antonio, Texas 78229,2
University of Texas at Austin College of Pharmacy, 1 University Station, A1900, Austin, Texas 78712,3
University of Texas Health Science Center at San Antonio, Pharmacotherapy Education and Research Center, MSC 6220, 7703 Floyd Curl Drive, San Antonio, Texas 782994
Received 9 April 2008/
Returned for modification 23 June 2008/
Accepted 20 July 2008
We report a case of Candida glabrata invasive candidiasis that developed reduced susceptibility to caspofungin during prolonged therapy. Pre- and posttreatment isolates were confirmed to be isogenic, and sequencing of hot spots known to confer echinocandin resistance revealed an F659V substitution within the FKS2 region of the glucan synthase complex.
* Corresponding author. Mailing address: Department of Internal Medicine, Division of Infectious Diseases, UTHSCSA, 7703 Floyd Curl Drive, San Antonio, TX 78229. Phone: (210) 567-6680. Fax: (210) 567-3303. E-mail:
thompsong2{at}uthscsa.edu
Published ahead of print on 1 August 2008.
Antimicrobial Agents and Chemotherapy, October 2008, p. 3783-3785, Vol. 52, No. 10
0066-4804/08/$08.00+0 doi:10.1128/AAC.00473-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S., Jones, R. N., Turnidge, J., Diekema, D. J.
(2010). Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp.. J. Clin. Microbiol.
48: 52-56
[Abstract]
[Full Text]
-
Arendrup, M. C., Garcia-Effron, G., Lass-Florl, C., Lopez, A. G., Rodriguez-Tudela, J.-L., Cuenca-Estrella, M., Perlin, D. S.
(2010). Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media. Antimicrob. Agents Chemother.
54: 426-439
[Abstract]
[Full Text]
-
Garcia-Effron, G., Lee, S., Park, S., Cleary, J. D., Perlin, D. S.
(2009). Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-{beta}-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint. Antimicrob. Agents Chemother.
53: 3690-3699
[Abstract]
[Full Text]
-
Katiyar, S. K., Edlind, T. D.
(2009). Role for Fks1 in the Intrinsic Echinocandin Resistance of Fusarium solani as Evidenced by Hybrid Expression in Saccharomyces cerevisiae. Antimicrob. Agents Chemother.
53: 1772-1778
[Abstract]
[Full Text]